Prostate Cancer
A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels - Abstract
September 26, 2014
Random variation in rectal position during radiotherapy for prostate cancer is two to three times greater than that predicted from prostate motion - Abstract
September 26, 2014
PROVENGE® (sipuleucel-T) demonstrates positive immune responses when sequenced with other therapies in advanced prostate cancer
September 26, 2014
Incidence and clinicopathological characteristics of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens - Abstract
September 25, 2014
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients - Abstract
September 25, 2014
Cardiovascular risk profile of veteran men beginning androgen deprivation therapy - Abstract
September 25, 2014
New era of the treatment of CRPC in Japan - Abstract
September 25, 2014
Resource utilization and use of life-extending therapies and corticosteroids in prostate cancer patients with corticosteroid-sensitive comorbidities - Abstract
September 25, 2014
Enzalutamide in European and North American men participating in the AFFIRM trial - Abstract
September 25, 2014
Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases - Abstract
September 25, 2014
Survival disparities between Māori and non-Māori men with prostate cancer in New Zealand - Abstract
September 25, 2014
Prostate pointers and pitfalls: The 10 most prevalent problems in prostate biopsy interpretation - Abstract
September 24, 2014
Utility of an initial adaptive bladder volume control with ultrasonography for proton-beam irradiation for prostate cancer - Abstract
September 24, 2014
Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy - Abstract
September 24, 2014